New hope for easing Chemo's worst side effect
NCT ID NCT06554184
Summary
This large, completed study tested whether a new drug called HR20013 works better than a standard drug (palonosetron) at preventing nausea and vomiting in cancer patients receiving chemotherapy that has a moderate risk of causing these side effects. It involved 706 adults who were new to chemotherapy. The main goal was to see if patients had no vomiting and didn't need extra rescue medicine, especially in the days after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA AND VOMITING ASSOCIATED WITH MODERATE EMETIC RISK ANTICANCER AGENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center Yuexiu Campus
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.